Sponsored By

Gerresheimer (Düsseldorf, Germany), a supplier of glass and plastic products to the pharmaceutical and medical device industries, has announced the acquisition of Centor (Perrysburg, OH) in a cash deal valued at $725 million. It has reached an agreement with Nemera Development S.A. to acquire 100% of the shares of Centor, a leading manufacturer of plastic vials and closures for oral drugs in the U.S. prescription retail market.

PlasticsToday Staff

August 24, 2015

1 Min Read
Gerresheimer buys plastic vials and closures maker Centor

CentorCentor manufactures the industry-standard Screw-Loc child-resistant package and the 1-Clic vial, which emits an audible click to ensure proper closing. The deal will expand Gerresheimer's footprint in the U.S. pharma packaging market.

"[The acquisition] is a perfect fit to extend our product offering from packaging of parenterals to the packaging of oral drugs in the United States," said Gerresheimer CEO Uwe Röhrhoff in a prepared statement. "We expect that this acquisition will increase shareholder value significantly."

Subject to regulatory approval, the acquisition is expected to close in the fourth quarter of 2015. Centor will be integrated in the plastics and devices division of Gerresheimer.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like